Literature DB >> 15858455

Longitudinal consistency of the relationship between depression symptoms and cognitive functioning in multiple sclerosis.

Peter A Arnett1.   

Abstract

BACKGROUND: Lifetime prevalence rates of cognitive dysfunction and depression in multiple sclerosis (MS) have typically been reported to be approximately 50 percent. However, an inconsistent relationship between these two common features of MS has been reported in the literature. Because neurovegetative depression symptoms overlap with MS symptoms, it may be that literature inconsistencies can partly be explained by the fact that only those depression symptom clusters unambiguously reflective of depression are associated with cognitive dysfunction.
OBJECTIVE: To explore the relationship between different depression symptom clusters and a battery of tests measuring cognitive domains commonly impaired in MS and was examined at two time points 3 years apart.
METHODS: The Chicago Multiscale Depression Inventory was employed to measure mood, negative evaluative, and neurovegetative symptom clusters in 53 MS patients who were also administered a battery of neuropsychological tests.
RESULTS: At time point 1, Mood and Evaluative Chicago Multiscale Depression Inventory scales were significantly associated with tasks of complex speeded attention, planning, and working memory. At time point 2, the Evaluative scale was still significantly associated with these domains, in addition to spatial memory; however, all of the significant correlations with the Mood scale dropped out.
CONCLUSION: These results show that negative evaluative depression symptoms are most consistently predictive of cognitive dysfunction in MS. It may be that negative evaluative depression symptoms use up available cognitive capacity, thus compromising performance on cognitive capacity demanding tasks in MS patients.

Entities:  

Mesh:

Year:  2005        PMID: 15858455     DOI: 10.1017/s1092852900022744

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  9 in total

1.  Relationship between depression, fatigue, subjective cognitive impairment, and objective neuropsychological functioning in patients with multiple sclerosis.

Authors:  Sarah W Kinsinger; Emily Lattie; David C Mohr
Journal:  Neuropsychology       Date:  2010-09       Impact factor: 3.295

2.  Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure.

Authors:  Ruth Ann Marrie; Ronak Patel; Chase R Figley; Jennifer Kornelsen; James M Bolton; Lesley A Graff; Erin L Mazerolle; Carl Helmick; Md Nasir Uddin; Teresa D Figley; James J Marriott; Charles N Bernstein; John D Fisk
Journal:  Front Neurol       Date:  2022-05-24       Impact factor: 4.086

3.  The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.

Authors:  Jelena Dackovic; Tatjana Pekmezovic; Sarlota Mesaros; Irena Dujmovic; Nebojsa Stojsavljevic; Vanja Martinovic; Jelena Drulovic
Journal:  Neurol Sci       Date:  2016-05-20       Impact factor: 3.307

4.  aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis.

Authors:  Vivien Häußler; Friederike Ufer; Jana Pöttgen; Christine Wolschke; Manuel A Friese; Nicolaus Kröger; Christoph Heesen; Jan-Patrick Stellmann
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

5.  Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.

Authors:  Domenica Nunnari; Maria Cristina De Cola; Giangaetano D'Aleo; Carmela Rifici; Margherita Russo; Edoardo Sessa; Placido Bramanti; Silvia Marino
Journal:  Biomed Res Int       Date:  2015-03-11       Impact factor: 3.411

6.  Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression.

Authors:  Lampros Samartzis; Efthymia Gavala; Yiannis Zoukos; Achilleas Aspiotis; Thomas Thomaides
Journal:  Rehabil Res Pract       Date:  2014-09-01

7.  Recommendations for observational studies of comorbidity in multiple sclerosis.

Authors:  Ruth Ann Marrie; Aaron Miller; Maria Pia Sormani; Alan Thompson; Emmanuelle Waubant; Maria Trojano; Paul O'Connor; Kirsten Fiest; Nadia Reider; Stephen Reingold; Jeffrey A Cohen
Journal:  Neurology       Date:  2016-02-10       Impact factor: 9.910

8.  Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.

Authors:  Gabriel Bsteh; Rainer Ehling; Andreas Lutterotti; Harald Hegen; Franziska Di Pauli; Michael Auer; Florian Deisenhammer; Markus Reindl; Thomas Berger
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

9.  Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders.

Authors:  Ruth Ann Marrie; Ronak Patel; Charles N Bernstein; James M Bolton; Lesley A Graff; James J Marriott; Carol A Hitchon; Chase R Figley; Jennifer Kornelsen; John D Fisk
Journal:  Mult Scler       Date:  2020-09-25       Impact factor: 6.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.